Login

Forgot password?
Sign up today and your first download is free.
REGISTER

Rx Drugs

March 29, 2019 | Daily News

The House passed Monday (March 25) legislation to stop drug companies from avoiding Medicaid rebates by misclassifying brand drugs as generics, but the bill could face opposition in the Senate even though the upper chamber's original Right Rebate Act was bipartisan.

March 29, 2019 | Daily News

New York state has filed a lawsuit against opioid makers and distributors and the Sackler family, which founded Purdue Pharma and developed OxyContin, for false and deceptive marketing of opioids that the state alleges helped spur the opioid epidemic, New York Attorney General Letitia James announced Thursday (March 28).

March 28, 2019 | Daily News

Senate health committee chair Lamar Alexander (R-TN) said Thursday (March 28) that he is working with health committee ranking Democrat Patty Murray (WA), Senate Finance Committee Chair Chuck Grassley (R-IA) and ranking Democrat Ron Wyden (OR) to develop a bill in each committee to lower health care costs by summer.

March 27, 2019 | Daily News

Republicans on the House Energy & Commerce Committee tried in vain on Wednesday (March 27) to amend bills aimed at speeding generic competition.

March 27, 2019 | Daily News

House Energy & Commerce oversight and investigations subcommittee Chair Diana DeGette (D-CO) said Tuesday (March 26) that she has no plans to hold oversight hearings on the 340B drug discount program.

March 26, 2019 | Daily News

Purdue Pharma, the manufacturer of OxyContin, has settled with the state of Oklahoma for $270 million in the state’s opioid litigation against multiple opioid makers over their allegedly deceptive marketing practices.

March 26, 2019 | Daily News

House Democrats repeatedly asked how the Trump administration would meet its goals of eradicating new HIV transmissions by 2030 if the proposed budget would cut $1.3 trillion from the Medicaid program.

March 26, 2019 | Daily News

The Louisiana Department of Health picked Gilead subsidiary Asegua Therapeutics to fulfill its first-in-the nation subscription model to provide hepatitis C drugs to state Medicaid and corrections populations, the department announced Tuesday (March 26).

March 25, 2019 | Daily News

The Energy & Commerce health subcommittee is scheduled to mark up Wednesday (March 27) a dozen health care bills, half of which are drug pricing bills and half of which would undo changes Republicans made to the Affordable Care Act.

March 22, 2019 | Daily News

CVS Health this week is pressing drug makers to hold off raising net prices to help the insurer accurately set Medicare Part D bids for 2020, according to a CVS letter to 60 drug makers obtained by Inside Drug Pricing.

March 22, 2019 | Daily News

White House officials are talking with staff for House Speaker Nancy Pelosi (D-CA) about drug-pricing legislation that could be included in a spending bill this fall, while Senate Finance Committee staff gear up to write a drug- pricing bill they hope could pass this summer, sources following the machinations of drug pricing legislation say.

March 21, 2019 | Daily News

A prominent consumer advocacy group and an FDA advisory committee chair are calling for FDA drug center chef Janet Woodcock to step down from her post in order to clear a path for the agency to revamp its regulation of opioids and implement recommendations made in 2017 by the National Academies of Sciences, Engineering, and Medicine.

March 21, 2019 | Daily News

A prominent consumer advocacy group and an FDA advisory committee chair filed a citizen petition on Thursday (March 21) demanding FDA slap an immediate moratorium on the approval of new opioids until it revamps its regulation and review of new opioids as recommended by the National Academies of Sciences, Engineering, and Medicine in 2017.

March 20, 2019 | Daily News

FDA Commissioner Scott Gottlieb said he will testify before Congress in support of FDA’s 2020 budget on April 3, before leaving the agency two days later.

March 20, 2019 | Daily News

Outgoing FDA Commissioner Scott Gottlieb on Tuesday (March 19) blamed insurers and pharmacy benefit managers for slower biosimilar uptake in the United States than in Europe.

March 18, 2019 | Daily News

Congressional Medicare advisers blasted Congress for changes to the Medicare coverage gap last year and asked lawmakers to make plans responsible for a larger share of prescription drug costs in Part D.

March 14, 2019 | Daily News

A bipartisan group of more than 70 House lawmakers wants CMS to withdraw a proposal to weaken coverage protections in six classes of drugs, according to a March 13 letter to HHS Secretary Alex Azar.

March 14, 2019 | Daily News

A bipartisan bill is being introducing Thursday (March 14) to let CMS share drug-pricing data with congressional advisers for Medicare and Medicaid policies.

March 14, 2019 | Daily News

House Energy & Commerce Committee Chair Frank Pallone (D-NJ) said Wednesday (March 13) that drug-pricing policy proposals that are likely to pass in Congress this session would benefit Medicare more than the commercial market.

March 14, 2019 | Daily News

Although the HHS proposal to eliminate rebates is aimed at reducing seniors’ cost sharing by lowering list prices for branded drugs, the proposed rule also could solve the so-called rebate trap that has thwarted biosimilars competition, Association for Accessible Medicines President and CEO Chip Davis said.

Pages